TCDD elevates erbB2 expression and signaling in T47D cells by reversing serum potentiation of estrogen receptor activity, independent of estrogen levels and enhanced ER down-regulation

Molecular and Cellular Endocrinology

Volumn 170, Issue 1-2, 2000, Pages 1-13

  Angus, William G R ^a   Campaigne Larsen, Michele ^a   Jefcoate, Colin R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast cancer; Breast tumor cells; ErbB2; ErbB3; Estrogen receptor; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; NEU DIFFERENTIATION FACTOR; RECEPTOR SUBTYPE;

BREAST TUMOR; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME INDUCTION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; SERUM; SIGNAL TRANSDUCTION;

EID: 0034704415     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00337-3     Document Type: Article

References (64)

1. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence
2. Proteosome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation
3. Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis
4. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combitorial ligand-receptor interactions
5. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status
6. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
7. + RNA
8. An intron 1 enhancer element mediates oestrogen-induced suppression of ErbB2 expression
9. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activity
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced activation of a protein tyrosine kinase, pp60src, in murine hepatic cytosol using a cell-free system
11. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3
12. Indole-3-carbinol and diindoylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells
13. Co-expression of human CYP1A1 and a human analog of cytochrome P450-EF in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human mammary carcinoma-derived MCF-7 cells
14. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells
15. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells - role of estrogen receptor SP1 complex formation
16. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells
17. Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells
18. High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness
19. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells
20. Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin
21. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin
22. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 12-O-tetradecanoylphorbol-13-acetate and 17-beta-estradiol on estrogen receptor regulation in MCF-7 human breast cancer cells
23. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression
24. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
25. Bidirectional interactions between the estrogen receptor and the cerbB-2 signaling pathways: heregulin inhibits estrogenic effects in breast cancer cells
26. Phosphatidylinositol 3-kinase mediates heregulin-induced growth inhibition in human epithelial cells
27. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds on the occupied nuclear estrogen receptor in MCF-7 human breast cancer cells
28. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1
29. ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors
30. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements
31. P300 and estrogen receptor cooperatively activate transcription via diffenential enhancement of initiation and reinitiation
32. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors
33. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells
34. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships
35. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenxo-p-dioxin (TCDD) in MCF-7 cells
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
37. Expression of the ERBB3 gene product in breast cancer
38. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators
39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane
40. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells
41. Organochlorine residues in human blood and biopsy fat and their relationship
42. Regulation of p70s6k/p85s6k and its role in the cell cycle
43. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
44. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation
45. Neu differentiation factor. Neuregulin isoforms activate distinct receptor combinations
46. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family
47. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk or recurrent disease
48. The modular phosphorylation and activation of p70s6k
49. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor
50. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells
51. TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation
52. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells
53. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
54. Ligand-dependent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1
55. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms
56. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
57. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
58. Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells
59. Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes
60. Transcriptional activation of E2F1 gene expression by 17 beta-estradiol in MCF-7 cells is regulated by NF-Y-SP1/estrogen receptor interactions
61. Distinct characteristics of heregulin signals mediated by HER3 or HER4
62. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
63. Evidence for the mechanism of action of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated decrease of nuclear estrogen receptor levels in wild-type and mutant mouse Hepa 1c1c7 cells
64. Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells